InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Daskal Ilan, Chief Financial Officer. Insider active across 4 companies, notably Natus Medical INC. Cumulatively, 25 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €3.1m. History available since 11 June 2021. The latest transaction was filed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Daskal Ilan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
55,114 shares0Common StockSEC:0000912093-26-000072:0
24,857 shares@ US$36.54Common StockSEC:0000912093-26-000072:1
47,420 shares0Common StockSEC:0000912093-26-000072:2
21,387 shares@ US$36.54Common StockSEC:0000912093-26-000072:3
30,257 shares@ US$36.29Common StockSEC:0000912093-26-000074:0
26,033 shares@ US$36.29Common StockSEC:0000912093-26-000074:1
25,100 shares@ US$17.8436.6% of flowCommon StockSEC:0000912093-25-000213:0
62,645 shares0Common StockSEC:0000912093-25-000207:0
70,545 shares0Common StockSEC:0000912093-25-000129:0
55,115 shares0Common StockSEC:0000912093-25-000102:0
82,095 shares@ US$9.28100.0% of flowCommon StockSEC:0000912093-25-000075:0
39,783 shares0Common StockSEC:0001127602-24-028243:0
694 shares0Bio-Rad A Common StockSEC:0001062993-23-017644:0
243 shares@ US$466.246.2% of flowBio-Rad A Common StockSEC:0001062993-23-009008:1
700 shares0Bio-Rad A Common StockSEC:0001062993-23-009008:0
541 shares0Bio-Rad A Common StockSEC:0001062993-22-019274:0
455 shares0Bio-Rad A Common StockSEC:0001062993-22-019183:0
18,937 shares@ US$33.5063.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000092:0
5,075 shares0Common Stock, $0.001 par value per shareSEC:0000878526-22-000041:0
700 shares0Bio-Rad A Common StockSEC:0001062993-22-010014:0
270 shares@ US$820.0620.8% of flowBio-Rad A Common StockSEC:0001062993-21-008354:0
540 shares@ US$524.3026.6% of flowBio-Rad A Common StockSEC:0001062993-21-008242:0
1,400 shares@ US$309.8440.9% of flowBio-Rad A Common StockSEC:0001062993-21-007078:0
5,214 shares@ US$28.7715.7% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000061:0
2,500 shares@ US$27.467.0% of flowCommon Stock, $0.001 par vale per shareSEC:0000878526-21-000053:0
25 of 25 declarations
About Daskal Ilan
Daskal Ilan is Directeur Financier. He has filed 19 disclosures in total. Across the 19 most recent sampled filings, they cover the period from 2021-06-15 to 2025-12-03, with 0 in purchases and 1916256 in sales, and the most frequent transaction nature is Levée d'options. His listed companies are Bio-Rad Laboratories, INC., where he is EVP, Chief Financial Officer, Viavi Solutions INC., where he is EVP, CFO, and Natus Medical INC, where he is Director.
